Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis.
Ibnou Zekri Lassout N, Goyal V, Krantz E, Simon F, Neven A, Eriksson J, Saayman A, Satam V, Ruffell C, Victor S, Chenel M, Celebic A, Caplain H, Gillon JY, Deshmukh A, Antarkar A, Sjögren E, Ribeiro I.
Ibnou Zekri Lassout N, et al. Among authors: celebic a.
Clin Transl Sci. 2024 Sep;17(9):e13908. doi: 10.1111/cts.13908.
Clin Transl Sci. 2024.
PMID: 39291723
Free PMC article.
Clinical Trial.